Joincare Pharmaceutical Group Industry Co Ltd

Common Name

Joincare

Country

China (Mainland)

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

14,350

Ticker

600380

Exchange

SHANGHAI STOCK EXCHANGE

Website

www.joincare.com

Description

Joincare Pharmaceutical Group Co., Ltd. is a well-established entity in the pharmaceutical industry, focused on the research, development, and manufacturing of a wide array of medical products. The co... Show more

Financial Statements of Joincare

Below are the financial statements of Joincare, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of CNY	2024	2023
Total revenues	15,619.48^a	16,646.35^a
Operating revenues	15,619.48^a	16,646.35^a
Total operating costs	-11,986.2^a	-13,123.52^a
Operating costs	-5,827.85^a	-6,298.47^a
Operating tax and surcharges	-190.41^a	-203.21^a
Selling expenses	-3,922.97^a	-4,434.44^a
Administrative expenses	-911.6^a	-930.48^a
R&D expenses	-1,435.35^a	-1,661.76^a
Financial expenses	-301.98^a	-404.84^a
Interest expenses	-123.26^a	-146.73^a
Interest income	417.3^a	532.25^a
Other income	191.27^a	259.06^a
Investment income ('-' for loss)	64.37^a	79.47^a
Income from investments in associates and joint ventures	27.08^a	72.79^a
Gains from derecognition of financial assets at amortized cost gains from net exposure hedges ('-' for loss) gains from changes in fair values ('-' for loss)	-17.5^a	-25.42^a
Losses of credit impairment ('-' for loss)	-7.26^a	-16.85^a
Impairment loss of assets ('-' for loss)	-293.14^a	-312.37^a
Gains from disposal of assets ('-' for loss)	45.26^a	-0.17^a
Operating profit ('-' for loss)	3,616.28^a	3,506.57^a
Non-operating income	7.78^a	7.98^a
Non-operating expenses	-49.18^a	-48.99^a
Total profit ('-' for loss)	3,574.89^a	3,465.55^a
Income tax expenses	-592.14^a	-614.54^a
Net profit ('-' for loss)	2,982.75^a	2,851.02^a
Classified by business continuity	—	—
Net profit from ongoing operation ('-' for loss)	2,982.75^a	2,851.02^a
Net profit from discontinuing operation ('-' for loss)	0^a	0^a
Classified by ownership	—	—
Net profit attributable to shareholders of the parent company ('-' for loss)	1,386.57^a	1,442.78^a
Profit and loss of minority shareholders ('-' for loss)	1,596.18^a	1,408.24^a

Verified Sources Behind Joincare’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Joincare’s data sources below and access millions more through our Disclosure Search.

a. Joincare's Annual Report 2024

Trace every data point back to Joincare’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Joincare Pharmaceutical Group Industry Co Ltd

Financial Statements of Joincare

Verified Sources Behind Joincare’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Tasly Pharmaceutical Group Co Ltd

Hansoh Pharmaceutical Group Company Ltd

WuXi Biologics (Cayman) Inc

Genscript Biotech Corp

CSPC Pharmaceutical Group Ltd

Zai Lab Ltd